Deerland Probiotics & Enzymes Overview
- Year Founded
-
1990
- Status
-
Acquired/Merged
- Employees
-
320
- Latest Deal Type
-
M&A
- Financing Rounds
-
5
- Investments
-
2
Deerland Probiotics & Enzymes General Information
Description
Provider of contract manufacturing services intended to deliver probiotic, prebiotic and enzyme-based ingredients for a wide range of on-trend health applications. The company specializes in developing science-backed solutions that benefit microbiome health, using probiotic, prebiotic and enzyme technology, thereby collaborating with customers to develop innovative and proprietary formations along with providing regulatory support and performing specialty manufacturing services including bulk blends, liquids, hard shell capsules and tablets as well as bottling and labeling.
Contact Information
Website
www.deerland.comCorporate Office
- 3800 Cobb International Boulevard
- Kennesaw, GA 30152
- United States
Corporate Office
- 3800 Cobb International Boulevard
- Kennesaw, GA 30152
- United States
Deerland Probiotics & Enzymes Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Deerland Probiotics & Enzymes Comparisons
Industry
Financing
Details
Deerland Probiotics & Enzymes Competitors (5)
One of Deerland Probiotics & Enzymes’s 5 competitors is Merical, a Private Equity-Backed company based in Anaheim, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Merical | Private Equity-Backed | Anaheim, CA | ||||
| Arizona Nutritional Supplements | Formerly PE-Backed | Chandler, AZ | ||||
| Kaypeeyes Biotech Pvt | Corporation | Mysore, India | ||||
| BIO-CAT | Corporate Backed or Acquired | Troy, VA | ||||
| Lallemand | Corporation | Toronto, Canada |
Deerland Probiotics & Enzymes Patents
Deerland Probiotics & Enzymes Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2022407518-A1 | Bacillus clausii strain, compositions thereof, and methods of use | Pending | 08-Dec-2021 | ||
| CA-3239840-A1 | Bacillus clausii strain, compositions thereof, and methods of use | Pending | 08-Dec-2021 | ||
| EP-4444861-A1 | Bacillus clausii strain, compositions thereof, and methods of use | Pending | 08-Dec-2021 | ||
| US-20250170188-A1 | Bacillus clausii strain, compositions thereof, and methods of use | Pending | 08-Dec-2021 | ||
| WO-2023108055-A1 | Bacillus clausii strain, compositions thereof, and methods of use | Inactive | 08-Dec-2021 | A61K35/742 |
Deerland Probiotics & Enzymes Signals
Deerland Probiotics & Enzymes Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Deerland Probiotics & Enzymes Investments (2)
Deerland Probiotics & Enzymes’s most recent deal was a Buyout/LBO with Bifodan for . The deal was made on 31-Oct-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Bifodan | 31-Oct-2019 | Buyout/LBO | Pharmaceuticals | ||
| National Enzyme Company | 19-Jul-2018 | Buyout/LBO | BPO/Outsource Services |
Deerland Probiotics & Enzymes Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Bifodan | Hundested, Denmark | 1992 |
Deerland Probiotics & Enzymes FAQs
-
When was Deerland Probiotics & Enzymes founded?
Deerland Probiotics & Enzymes was founded in 1990.
-
Where is Deerland Probiotics & Enzymes headquartered?
Deerland Probiotics & Enzymes is headquartered in Kennesaw, GA.
-
What is the size of Deerland Probiotics & Enzymes?
Deerland Probiotics & Enzymes has 320 total employees.
-
What industry is Deerland Probiotics & Enzymes in?
Deerland Probiotics & Enzymes’s primary industry is BPO/Outsource Services.
-
Is Deerland Probiotics & Enzymes a private or public company?
Deerland Probiotics & Enzymes is a Private company.
-
What is the current valuation of Deerland Probiotics & Enzymes?
The current valuation of Deerland Probiotics & Enzymes is .
-
What is Deerland Probiotics & Enzymes’s current revenue?
The current revenue for Deerland Probiotics & Enzymes is .
-
How much funding has Deerland Probiotics & Enzymes raised over time?
Deerland Probiotics & Enzymes has raised $76.3M.
-
Who are Deerland Probiotics & Enzymes’s investors?
RoundTable Healthcare Partners has invested in Deerland Probiotics & Enzymes.
-
Who are Deerland Probiotics & Enzymes’s competitors?
Merical, Arizona Nutritional Supplements, Kaypeeyes Biotech Pvt, BIO-CAT, and Lallemand are competitors of Deerland Probiotics & Enzymes.
-
When was Deerland Probiotics & Enzymes acquired?
Deerland Probiotics & Enzymes was acquired on 19-Nov-2021.
-
Who acquired Deerland Probiotics & Enzymes?
Deerland Probiotics & Enzymes was acquired by Archer Daniels Midland.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process